NBRV - Nabriva Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts5277
Avg. Estimate-0.33-0.29-1.15-0.92
Low Estimate-0.41-0.3-1.24-1.13
High Estimate-0.28-0.29-1.05-0.74
Year Ago EPS-0.41-0.29-2.26-1.15
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts4267
Avg. Estimate1.83M3.75M11.4M27.03M
Low Estimate750k3.5M9.9M17.84M
High Estimate3.13M4M12.69M39.69M
Year Ago Sales797k580k9.66M11.4M
Sales Growth (year/est)129.60%546.60%18.10%137.10%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.32-0.32-0.33-0.28
EPS Actual-0.41-0.29-0.3-0.24
Difference-0.090.030.030.04
Surprise %-28.10%9.40%9.10%14.30%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.33-0.29-1.15-0.92
7 Days Ago-0.33-0.29-1.16-0.96
30 Days Ago-0.34-0.31-1.16-0.98
60 Days Ago-0.34-0.31-1.16-0.97
90 Days Ago-0.3-0.25-1.12-0.89
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/A11
Up Last 30 Days1122
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNBRVIndustrySectorS&P 500
Current Qtr.19.50%N/AN/A0.01
Next Qtr.N/AN/AN/A0.05
Current Year49.10%N/AN/A-0.02
Next Year20.00%N/AN/A0.14
Next 5 Years (per annum)97.20%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A